Evidence map›Paper›PMID 23063024›Full record

ArticleJournal of diabetes science and technology2012

Transitioning insulin pump therapy from the outpatient to the inpatient setting: a review of 6 years' experience with 253 cases.

Curtiss B Cook, Karen A Beer, Karen M Seifert, Mary E Boyle, Patricia A Mackey, Janna C Castro

Abstract readEvaluation Study
In one paragraph

Article in Journal of diabetes science and technology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. [Hospital diabetes management (Update 2026)].Wiener klinische Wochenschrift · 2026
    Guideline
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Guideline
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Digital Technology for Diabetes.The New England journal of medicine · 2023
    Review
  13. Article
  14. [Hospital diabetes management (Update 2023)].Wiener klinische Wochenschrift · 2023
    Article
  15. Article
  16. Article
  17. Insulin Delivery Hardware: Pumps and Pens.Diabetes technology & therapeutics · 2022
    Article
  18. Supporting the Use of a Person's Own Diabetes Technology in the Inpatient Setting.Diabetes spectrum : a publication of the American Diabetes Association · 2022
    Article
  19. Nutrients · 2021
    Article
  20. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia.Endocrinology and metabolism clinics of North America · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Curtiss B CookDivision of Endocrinology, Mayo Clinic, Scottsdale, Arizona 85259, USA. cook.curtiss@mayo.edu
Karen A Beer
Karen M Seifert
Mary E Boyle
Patricia A Mackey
Janna C Castro

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe reviewed the care of a large cohort of patients with diabetes mellitus on insulin pump therapy who required an inpatient stay.

methodsRecords were reviewed of patients hospitalized between January 1, 2006, and December 31, 2011.

resultsA total of 136 patients using insulin pumps had 253 hospitalizations. Mean (standard deviation) patient age was 55 (16) years, diabetes duration was 29 (15) years, and pump duration was 6 (5) years. Insulin pump therapy was continued in 164 (65%) hospitalizations. Adherence to core process measures improved over time: by 2011, 100% of cases had an endocrinology consultation, 100% had the required insulin pump order set completed, and 94% had documentation of the signed agreement specifying patient responsibilities for continued use of the technology while hospitalized. Documentation of the insulin pump flow sheet also increased but could still be located in only 64% of cases by the end of 2011. Mean glucose was not significantly different among patients who remained on insulin pump therapy compared to those for whom it was discontinued (p > .1), but episodes of severe hyperglycemia (>300 mg/dl) and hypoglycemia (<40 mg/dl) were significantly less common among pump users. No pump site infections, mechanical pump failures, or episodes of diabetic ketoacidosis were observed among patients remaining on therapy.

conclusionsWith appropriate patient selection and usage guidelines, most patients using insulin pumps can safely have their therapy transitioned to the inpatient setting. Further study is needed to determine whether this approach can be translated to other hospital settings.

Indexed as

Continuity of Patient CareInpatientsOutpatientsAdultAgedCohort StudiesDiabetes MellitusFemaleHospitalizationHumansHypoglycemic AgentsInfusions, SubcutaneousInsulinInsulin Infusion SystemsMaleMiddle AgedHypoglycemic AgentsInsulin

Identifiers

PMID23063024
PMCPMC3570832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.